# Inspire Medical Systems

continued to expand evidence for its next-generation hypoglossal nerve stimulation therapy for obstructive sleep apnea, presenting final ADHERE registry results covering more than 5,000 patients and the OSPREY randomized trial broadening neurostimulation options at SLEEP 2026 in June.

Source: https://en.bioecon.ru/companies/inspire-medical-systems/
Updated: 2026-07-20

- Country: United States
- Ticker: INSP

## Technologies

- [Bioelectronic medicine & neuromodulation](https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/)